Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 25
- 试验地点
- 7
- 主要终点
- Create Data Set
研究概览
简要总结
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.
Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All participants must be 18 years of age or older.
- •Subjects may be any stage and anywhere in the treatment continuum.
- •Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
- •Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- •All participants must be able to understand English.
排除标准
- •Any patient who cannot understand written or spoken English.
- •Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- •Any patient on a treatment clinical trial.
- •Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
结局指标
主要结局
Create Data Set
时间窗: 1 year
The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment
次要结局
未报告次要终点